跳至主要内容
临床试验/JPRN-UMIN000042621
JPRN-UMIN000042621已完成未知

Predictive capability of sarcopenia in patients treated with immune checkpoint inhibitors. A meta-analysis - effect of sarcopenia on cancer immunotherapy

Kansai medical hospital0 个研究点目标入组 2,501 人开始时间: 2020年12月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
2,501

研究概览

简要总结

A total of 2501 patients from 26 studies were analysed. Sarcopenia was observed in 44.7% of the patients and was significantly associated with poor survival.Poor radiological response to ICI therapy was observed in patients with sarcopenia.The occurrence of severe toxicity was not associated with sarcopenia.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • review, case report, animal study languages other than English or Japanese

研究者

相似试验

Predictive capability of sarcopenia in patients... | 临床试验